Free tool
FAERS Monitor: Keppra
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021505 or its brand name (Keppra, Levetiracetam). Reports on generic versions are filed under their own applications.
Reports
133,531
Serious
111,042
83% of reports
Hospitalization
49,622
Death reported
12,023
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- seizure15,769
- drug ineffective12,490
- off label use9,614
- fatigue5,592
- somnolence4,201
- epilepsy4,178
- convulsion3,988
- maternal exposure during pregnancy3,813
- fall3,746
- headache3,723
- nausea3,627
- dizziness3,594
- drug interaction3,507
- diarrhoea3,280
- condition aggravated3,250
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 515 |
| 2005 | 758 |
| 2006 | 908 |
| 2007 | 1,182 |
| 2008 | 1,355 |
| 2009 | 2,201 |
| 2010 | 2,447 |
| 2011 | 3,020 |
| 2012 | 3,954 |
| 2013 | 4,020 |
| 2014 | 4,593 |
| 2015 | 6,309 |
| 2016 | 8,121 |
| 2017 | 7,640 |
| 2018 | 10,346 |
| 2019 | 11,939 |
| 2020 | 9,879 |
| 2021 | 10,064 |
| 2022 | 8,884 |
| 2023 | 9,509 |
| 2024 | 9,901 |
| 2025 | 8,886 |
| 2026 | 7,096 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,920,628 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| epilepsySignal | 4,178 | 24.8 | 24.0 | 82,391 |
| seizureSignal | 15,769 | 24.7 | 24.4 | 311,949 |
| convulsionSignal | 3,988 | 11.7 | 11.4 | 36,514 |
| maternal exposure during pregnancySignal | 3,813 | 7.0 | 6.8 | 18,828 |
| drug interactionSignal | 3,507 | 3.5 | 3.4 | 6,289 |
| somnolenceSignal | 4,201 | 3.3 | 3.2 | 6,787 |
| fall | 3,746 | 1.8 | 1.7 | 1,290 |
| off label use | 9,614 | 1.7 | 1.7 | 3,105 |
| condition aggravated | 3,250 | 1.7 | 1.6 | 921 |
| drug ineffective | 12,490 | 1.5 | 1.5 | 2,181 |
| dizziness | 3,594 | 1.1 | 1.1 | 59 |
| fatigue | 5,592 | 1.1 | 1.1 | 89 |
| headache | 3,723 | 0.9 | 0.9 | 17 |
| diarrhoea | 3,280 | 0.8 | 0.8 | 169 |
| nausea | 3,627 | 0.7 | 0.7 | 406 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.